Literature DB >> 21544429

Mechanisms of the formation of the peritoneal dissemination in gastric cancer.

Y Yonemura1, Y Endo, T Yamaguchi, T Fujimura, T Obata, T Kawamura, N Nojima, I Miyazaki, T Sasaki.   

Abstract

To clarify the mechanisms of the formation of peritoneal dissemination, a new animal model by the i.p. inoculation of highly metastatic gastric cancer cell line MKN-45-P was developed. Peritoneal dissemination with bloody ascites was found in 100% of nude mice, injected 1x10(7) MKN-45-P cells in suspension into the peritoneal cavity. By a highly sensitive method for specific detection of metastasized human tumor cells in nude mice using polymerase chain reaction, a human beta-globin-related sequence in the DNA from various parts of the peritoneum was specifically amplified and detected by gel electrophoresis and by a specific oligonucleotide probe. Greater omentum showed a strong signal of the amplified fragments of human beta-globin gene from the 1st day and the signals gradually increased. The signals in the gonadal fat, mesentery and ovarium could be weakly detected on the Ist day, transiently decreased on the 3rd day, and then increased from the 7th day. In the diaphragm, and abdominal wall, signals could be detected from the 7th day. In contrast, small intestine and colon did not show any human beta-globin signals. In greater omentum and gonadal fat, cancer cells were selectively detected in the milky spots stained by activated carbon on the 3rd day. In the diaphragm, cancer cells adhered to the small pores termed stomata, and invaded into the subdiaphragmatic lymphatic lacunae connected with stomata. From the 3rd day, mesothelial cells of the abdominal cavity became round and separated, resulting in the exposure of the underlying connective tissue. MKN-45-P cells were found to adhere to the naked areas of the submesothelial connective tissue. From these results, we conclude that the major metastatic route of the peritoneum may be firstly through milky spots, secondly through the diaphragmatic stomata, and thirdly by the adhesion to the naked connective tissue exposed after shrinkage of the mesothelial cells. The third process may be related to the interaction between some adhesion molecules and their ligands.

Entities:  

Year:  1996        PMID: 21544429     DOI: 10.3892/ijo.8.4.795

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer.

Authors:  Motoshi Miyagi; Keishiro Aoyagi; Seiya Kato; Kazuo Shirouzu
Journal:  Int J Clin Oncol       Date:  2007-02-25       Impact factor: 3.402

2.  Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model.

Authors:  Takuya Imaizumi; Keishiro Aoyagi; Motoshi Miyagi; Kazuo Shirouzu
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

3.  TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line.

Authors:  Yoshinari Mochizuki; Hayao Nakanishi; Yasuhiro Kodera; Seiji Ito; Yoshitaka Yamamura; Tomoyuki Kato; Kenji Hibi; Seiji Akiyama; Akimasa Nakao; Masae Tatematsu
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer.

Authors:  Keishiro Aoyagi; Kikuo Kouhuji; Motoshi Miyagi; Junya Kizaki; Taro Isobe; Kousuke Hashimoto; Kazuo Shirouzu
Journal:  World J Crit Care Med       Date:  2013-11-04

5.  VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody.

Authors:  Sachio Fushida; Katsunobu Oyama; Jun Kinoshita; Yasumichi Yagi; Kouichi Okamoto; Hidehiro Tajima; Itasu Ninomiya; Takashi Fujimura; Tetsuo Ohta
Journal:  Onco Targets Ther       Date:  2013-10-16       Impact factor: 4.147

6.  Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.

Authors:  Mitsuyoshi Okazaki; Sachio Fushida; Shinichi Harada; Tomoya Tsukada; Jun Kinoshita; Katsunobu Oyama; Tomoharu Miyashita; Itasu Ninomiya; Tetsuo Ohta
Journal:  BMC Cancer       Date:  2017-01-05       Impact factor: 4.430

7.  Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast.

Authors:  Hiroto Saito; Sachio Fushida; Shinichi Harada; Tomoharu Miyashita; Katsunobu Oyama; Takahisa Yamaguchi; Tomoya Tsukada; Jun Kinoshita; Hidehiro Tajima; Itasu Ninomiya; Tetsuo Ohta
Journal:  Gastric Cancer       Date:  2017-05-24       Impact factor: 7.370

Review 8.  Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum.

Authors:  Lieselotte Lemoine; Paul Sugarbaker; Kurt Van der Speeten
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

9.  Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway.

Authors:  Xiaoxun Wang; Xiaofang Che; Yang Yu; Yu Cheng; Ming Bai; Zichang Yang; Qiqiang Guo; Xiaochen Xie; Danni Li; Min Guo; Kezuo Hou; Wendong Guo; Xiujuan Qu; Liu Cao
Journal:  J Exp Clin Cancer Res       Date:  2020-10-20

10.  Interleukin-17A derived from mast cells contributes to fibrosis in gastric cancer with peritoneal dissemination.

Authors:  Katsuya Gunjigake; Jun Kinoshita; Takahisa Yamaguchi; Hiroto Saito; Daisuke Fujimori; Toshihide Horiike; Shinichi Harada; Hidehiro Tajima; Itasu Ninomiya; Tetsuo Ohta; Sachio Fushida
Journal:  Gastric Cancer       Date:  2020-06-02       Impact factor: 7.370

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.